EN HU

Szatmári István

Szatmári István

Publication list

Uploaded publications:
46
Publications in DEA:
46
OA:
19
Date range:
2000-2024
2024
1.
Balla, V., Németh, E., Szatmári, I., Péli-Szabó, J., Képes, Z., Trencsényi, G., Kertész, I., Forgács, V., Jószai, I.: Az SzR72 kinurénsav-analóg 11C izotóppal történő jelzése és preklinikai vizsgálata.
In: Őszi Radiokémiai Napok 2024 : A konferencia programja és előadás kivonatai, Magyar Kémikusok Egyesülete, Budapest, 33-38, 2024. ISBN: 9786156018267
2.
Póliska, S., Fareh, C., Lengyel, A., Göczi, L., Tőzsér, J., Szatmári, I.: Comparative transcriptomic analysis of Illumina and MGI next-generation sequencing platforms using RUNX3- and ZBTB46-instructed embryonic stem cells.
Front. Genet. 14, 1-14, (article identifier: 1275383), 2024.
Journal metrics:
Q2 Genetics (2023)
Q2 Genetics (clinical) (2023)
Q2 Molecular Medicine (2023)
3.
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.
Journal metrics:
D1 Medicine (miscellaneous) (2023)
2023
4.
Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I. P., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, (article identifier: 217), 2023.
Journal metrics:
Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
D1 Medicine (miscellaneous)
2022
5.
Laczik, M., Erdős, E., Ozgyin, L., Hevessy, Z., Csősz, É., Kalló, G., Nagy, T., Barta, E., Póliska, S., Szatmári, I., Bálint, B. L.: Extensive proteome and functional genomic profiling of variability between genetically identical human B-lymphoblastoid cells.
Sci Data. 9 (1), 1-12, 2022.
Journal metrics:
D1 Computer Science Applications
D1 Education
D1 Library and Information Sciences
D1 Information Systems
D1 Statistics and Probability
D1 Statistics, Probability and Uncertainty
6.
Czimmerer, Z., Halász, L., Dániel, B., Varga, Z., Bene, K., Domokos, A., Hoeksema, M., Shen, Z., Berger, W. K., Silye-Cseh, T., Jambrovics, K., Kolostyák, Z., Fenyvesi, F., Váradi, J., Póliska, S., Hajas, G., Szatmári, I., Glass, C. K., Bácsi, A., Nagy, L.: The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands.
Immunity. 55 (11), 2006-2026, 2022.
Journal metrics:
D1 Immunology
D1 Immunology and Allergy
D1 Infectious Diseases
2021
7.
Botó, P., Gerzsenyi, T. B., Lengyel, A., Szúnyog, B., Szatmári, I.: Zbtb46-dependent altered developmental program in embryonic stem cell-derived blood cell progenitors.
Stem Cells. 39 (10), 1322-1334, 2021.
Journal metrics:
Q2 Cell Biology
Q1 Developmental Biology
Q1 Medicine (miscellaneous)
Q1 Molecular Medicine
2020
8.
Dániel, B., Czimmerer, Z., Halász, L., Botó, P., Kolostyák, Z., Póliska, S., Berger, W. K., Tzerpos, P., Nagy, G., Horváth, A., Hajas, G., Silye-Cseh, T., Nagy, A., Sauer, S., Francois-Deleuze, J., Szatmári, I., Bácsi, A., Nagy, L.: The transcription factor EGR2 is the molecular linchpin connecting STAT6 activation to the late, stable epigenomic program of alternative macrophage polarization.
Genes Dev. 34 (21-22), 1474-1492, 2020.
Journal metrics:
D1 Developmental Biology
D1 Genetics
2019
9.
Smith, D. G., Martinelli, R., Besra, G. S., Illarionov, P. A., Szatmári, I., Brázda, P., Allen, M. A., Xu, W., Wang, X., Nagy, L., Dowell, R. D., Rook, G. A. W., Rosa, B. L., Lowry, C. A.: Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties.
Psychopharmacology. 236 (5), 1653-1670, 2019.
Journal metrics:
Q1 Pharmacology
2018
10.
Agostini, M., Schoenmakers, E., Beig, J., Fairall, L., Szatmári, I., Rajanayagam, O., Muskett, F. W., Adams, C., Marais, A. D., O'Rahilly, S., Semple, R. K., Nagy, L., Majithia, A. R., Schwabe, J. W. R., Blom, D. J., Murphy, R., Chatterjee, K., Savage, D. B.: A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations.
Diabetes. 67 (6), 1086-1092, 2018.
Journal metrics:
D1 Endocrinology, Diabetes and Metabolism
D1 Internal Medicine
11.
Botó, P., Csuth, T. I., Szatmári, I.: RUNX3-Mediated Immune Cell Development and Maturation.
Crit. Rev. Immunol. 38 (1), 63-78, 2018.
Journal metrics:
Q3 Immunology
Q3 Immunology and Allergy
2017
12.
Takács, E., Botó, P., Simó, E., Csuth, T. I., Tóth, B., Raveh-Amit, H., Pap, A., Kovács, E. G., Kobolák, J., Benkő, S., Dinnyés, A., Szatmári, I.: Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3.
J. Immunol. 198 (1), 239-248, 2017.
Journal metrics:
Q1 Immunology
13.
Kiss, M., Czimmerer, Z., Nagy, G., Bieniasz-Krzywiec, P., Ehling, M., Pap, A., Póliska, S., Botó, P., Tzerpos, P., Horváth, A., Kolostyák, Z., Dániel, B., Szatmári, I., Mazzone, M., Nagy, L.: Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism.
Proc. Natl. Acad. Sci. U. S. A. 114 (40), 10725-10730, 2017.
Journal metrics:
D1 Multidisciplinary
2016
14.
Bencsik, R., Botó, P., Szabó, R. N., Tóth, B., Simó, E., Bálint, B. L., Szatmári, I.: Improved transgene expression in doxycycline-inducible embryonic stem cells by repeated chemical selection or cell sorting.
Stem Cell Res. 17 (2), 228-234, 2016.
Journal metrics:
Q2 Cell Biology
Q1 Developmental Biology
D1 Medicine (miscellaneous)
2013
15.
Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernandez, V. H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., Balázs, M.: Integrative genomics identifies gene signature associated with melanoma ulceration.
PLoS One. 8 (1), e54958, 2013.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
16.
Kis-Tóth, K., Bacskai, I., Gogolák, P., Türk-Mázló, A., Szatmári, I., Rajnavölgyi, É.: Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001.
Immunobiology. 218 (11), 1361-1369, 2013.
Journal metrics:
Q1 Hematology
Q2 Immunology
Q1 Immunology and Allergy
17.
Gyöngyösi, A., Szatmári, I., Pap, A., Dezső, B., Pos, Z., Széles, L., Varga, T., Nagy, L.: RDH10, RALDH2, and CRABP2 are required components of PPARγ-directed ATRA synthesis and signaling in human dendritic cells.
J. Lipid Res. 54 (9), 2458-2474, 2013.
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
D1 Endocrinology
2012
18.
Tsakiris, I., Töröcsik, D., Gyöngyösi, A., Dózsa, A., Szatmári, I., Szántó, A., Soós, G., Nemes, Z., Igali, L., Márton, I., Takáts, Z., Nagy, L., Dezső, B.: Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.
Lab. Invest. 92 (3), 345-361, 2012.
Journal metrics:
Q2 Cell Biology
Q2 Molecular Biology
D1 Pathology and Forensic Medicine
19.
Nagy, L., Szántó, A., Szatmári, I., Széles, L.: Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response.
Physiol. Rev. 92 (2), 739-789, 2012.
Journal metrics:
D1 Medicine (miscellaneous)
D1 Molecular Biology
D1 Physiology
D1 Physiology (medical)
20.
Szatmári, I., Fésüs, L.: Pluripotens sejtek alkalmazása a jelen és a jövő orvostudományában.
Meditor. 1-2, 64-81, 2012.
2011
21.
Póliska, S., Csánky, E., Szántó, A., Szatmári, I., Meskó, B., Széles, L., Dezső, B., Scholtz, B., Podani, J., Kilty, I., Takács, L., Nagy, L.: Chronic Obstructive Pulmonary Disease-Specific Gene Expression Signatures of Alveolar Macrophages as well as Peripheral Blood Monocytes Overlap and Correlate with Lung Function.
Respiration. 81 (6), 499-510, 2011.
Journal metrics:
Q1 Pulmonary and Respiratory Medicine
22.
Iacovino, M., Chong, D., Szatmári, I., Hartweck, L., Rux, D., Caprioli, A., Cleaver, O., Kyba, M.: HoxA3 is an apical regulator of haemogenic endothelium.
Nat. Cell Biol. 13 (1), 72-78, 2011.
Journal metrics:
D1 Cell Biology
23.
Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molecular therapies.
University of Debrecen, Debrecen, 120 p., 2011.
24.
Aradi, J., Balajthy, Z., Csősz, É., Scholtz, B., Szatmári, I., Tőzsér, J., Varga, T.: Molekuláris terápiák.
Debreceni Egyetem, Debrecen, 112 p., 2011.
25.
Nakken, B., Varga, T., Szatmári, I., Széles, L., Gyöngyösi, A., Illarionov, P. A., Dezső, B., Gogolák, P., Rajnavölgyi, É., Nagy, L.: Peroxisome proliferator-activated receptor [gamma]-regulated cathepsin D is required for lipid antigen presentation by dendritic cells.
J. Immunol. 187 (1), 240-247, 2011.
Journal metrics:
D1 Immunology
DEENK University of Debrecen
© 2012 University of Debrecen